{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Ma C"],"funding":["Beijing Municipal Commission of Education"],"pagination":["6661667"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7952185"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["2021"],"pubmed_abstract":["<h4>Background</h4>Qingdu Decoction (QDD) is a traditional Chinese medicine formula for treating chronic liver injury (CLI). <i>Materials and methods</i>. A network pharmacology combining experimental validation was used to investigate potential mechanisms of QDD against CLI. We firstly screened the bioactive compounds with pharmacology analysis platform of the Chinese medicine system (TCMSP) and gathered the targets of QDD and CLI. Then, we constructed a compound-target network and a protein-protein interaction (PPI) network and enriched core targets in Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathways. At last, we used a CLI rat model to confirm the effect and mechanism of QDD against CLI. Enzyme-linked immunosorbent assay (ELISA), western blot (WB), and real-time quantit"],"journal":["Evidence-based complementary and alternative medicine : eCAM"],"pubmed_title":["Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Qingdu Decoction against Chronic Liver Injury."],"pmcid":["PMC7952185"],"funding_grant_id":["KM201810025001","16ZY01"],"pubmed_authors":["Zou H","Zhao M","Ma C","Jin S","Gao L","Du Y","Zhang Q","Wu X"],"additional_accession":[]},"is_claimable":false,"name":"Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Qingdu Decoction against Chronic Liver Injury.","description":"<h4>Background</h4>Qingdu Decoction (QDD) is a traditional Chinese medicine formula for treating chronic liver injury (CLI). <i>Materials and methods</i>. A network pharmacology combining experimental validation was used to investigate potential mechanisms of QDD against CLI. We firstly screened the bioactive compounds with pharmacology analysis platform of the Chinese medicine system (TCMSP) and gathered the targets of QDD and CLI. Then, we constructed a compound-target network and a protein-protein interaction (PPI) network and enriched core targets in Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathways. At last, we used a CLI rat model to confirm the effect and mechanism of QDD against CLI. Enzyme-linked immunosorbent assay (ELISA), western blot (WB), and real-time quantit","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021","modification":"2025-04-20T02:29:11.126Z","creation":"2025-04-20T02:29:11.126Z"},"accession":"S-EPMC7952185","cross_references":{"pubmed":["33747110"],"doi":["10.1155/2021/6661667"]}}